Mirae Asset Global Investments
BCYC icon

Mirae Asset Global Investments’s Bicycle Therapeutics BCYC Stock Holding History

Mirae Asset Global Investments’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.84K Sell
2,085
-332
-14% -$1.52K ﹤0.01% 1583
2026
Q1 		$11.2K Buy
2,417
+169
+8% +$966 ﹤0.01% 1491
2025
Q4 		$15.9K Buy
2,248
+461
+26% +$3.4K ﹤0.01% 1557
2025
Q3 		$13.8K Buy
1,787
+82
+5% +$619 ﹤0.01% 1536
2025
Q2 		$11.8K Buy
1,705
+241
+16% +$1.92K ﹤0.01% 1469
2025
Q1 		$13.1K Sell
1,464
-2
-0.1% -$24 ﹤0.01% 1440
2024
Q4 		$21.3K Buy
1,466
+124
+9% +$2.66K ﹤0.01% 1417
2024
Q3 		$31.1K Buy
1,342
+270
+25% +$6.23K ﹤0.01% 1375
2024
Q2 		$21.7K Buy
+1,072
New +$24.2K ﹤0.01% 1373

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Mirae Asset Global Investments's BCYC Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Bicycle Therapeutics (BCYC) stake by 14% in Q2 2026, selling an estimated $1.52K and leaving 2,085 shares worth $8.84K. The position accounts for ﹤0.01% of the portfolio, ranked #1583.

Mirae Asset Global Investments first reported a position in BCYC in Q2 2024 and has held it in 9 quarters since. The position peaked at $31.1K in Q3 2024. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Mirae Asset Global Investments held 2,085 shares of Bicycle Therapeutics worth $8.84K as of Q2 2026.
  • Mirae Asset Global Investments sold 332 Bicycle Therapeutics shares in Q2 2026, an estimated $1.52K.
  • Bicycle Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1583 holding.
  • Mirae Asset Global Investments first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global Investments's Bicycle Therapeutics position peaked at $31.1K in Q3 2024.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.